For this study, we used the Vienna Idiopathic Intracranial Hypertension (VIIH) database, a cohort comprising 151 patients with definite IIH according to modified Friedman criteria [12]
That said, coverage still depends on your plan, as some employers choose not to cover weight loss medications
GLP-1 side effects follow a different curve, worsening with each dose increase during the titration period, then gradually improving once the maintenance dose is reached and the body fully adjusts
Novo Nordisk offers a savings card for Wegovy that may reduce copays for commercially insured patients, though eligibility requirements apply and the program excludes government insurance beneficiaries
Moving to higher doses too fast can cause severe stomach issues like nausea, vomiting, and diarrhea, which might make you stop treatment altogether